Swiss drugmaker Novartis on Saturday said that its experimental drug secukinumab proved to be more effective than Enbrel at clearing psoriasis in a phase III clinical trial. According to the firm, the drug showed good results in a two late-stage clinical trials when used by patients suffering from moderate-to-severe plaque psoriasis. The study findings were presented at the American Academy … [Read more...]
You are here: Home / Archives for secukinumab